Spondyloarthropathies (incl. ankylosing spondylitis)
Rheumatology · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
HLA-B27-associated seronegative inflammatory arthropathies with axial and peripheral disease, enthesitis and extra-articular features. Exercise plus NSAIDs then biologics for active disease.
Red flags
- Refer rheumatology for inflammatory back pain <45y with features (NICE: back pain >3 months starting before 45 plus >=4 of the inflammatory criteria)
- Urgent same-day ophthalmology for acute red painful eye (uveitis)
- Admit for suspected spinal fracture, cauda equina or acute aortic complication
Assessment
Investigations
- Raised CRP/ESR (may be normal);
- RF/anti-CCP negative;
- HLA-B27 (supportive, not diagnostic)
- X-ray sacroiliac joints/spine: sacroiliitis, syndesmophytes, 'bamboo spine' (late)
- MRI SI joints detects early bone-marrow oedema before radiographic change
- Schober test for lumbar flexion; screen skin, bowel, eyes
- Use ASAS classification criteria
Management
- Education + regular physiotherapy/structured exercise is the cornerstone (especially axial)
- NSAIDs first-line (continuous for active axSpA)
- Peripheral disease: local steroid, sulfasalazine or methotrexate (little axial benefit)
- Failing NSAIDs: biologics - anti-TNF or IL- 17 inhibitor (secukinumab), or JAK inhibitor
- Treat reactive-arthritis trigger; smoking cessation;
- CVD/bone risk
Disposition
Refer rheumatology for inflammatory back pain <45y with features (NICE: back pain >3 months starting before 45 plus >=4 of the inflammatory criteria).
Complications & pitfalls
- Spinal ankylosis with fixed kyphosis and fracture risk (rigid spine fractures easily - low threshold for CT on trauma); restrictive lung disease; recurrent acute anterior uveitis; aortic regurgitation and conduction defects; cauda equina; osteoporosis; amyloidosis; and accelerated cardiovascular disease
Exam pearls
- A rigid ankylosed spine fractures with minor trauma and fractures are unstable and easily missed on plain films - have a low threshold for CT and treat as unstable. HLA-B27 supports but never confirms or excludes the diagnosis.
- Monitoring & follow-up: Use BASDAI/ASDAS and spinal metrology to track disease and guide biologic escalation/continuation. Monitor NSAID GI/renal/CVD risk and DMARD/biologic safety (TB screen, hepatitis, infection). Ongoing physiotherapy adherence, posture, bone density. Coordinate with ophthalmology, dermatology and gastroenterology.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.